19 hours Ago By Defense World Staff
Charles Schwab Investment Management Inc. raised its position in shares of Nutrien Ltd. (NYSE:NTR – Free Report) by 8.
3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,886,376 shares of the company’s stock after purchasing an additional 144,025 shares during the period. Charles Schwab Investment Management Inc.
owned approximately 0.38% of Nutrien worth $84,367,000 at the end of the most recent reporting period. A number of other large investors have also added to or reduced their stakes in the company.
Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Nutrien in the third quarter worth about $150,181,000. ARGA Investment Management LP increased its holdings in shares of Nutrien by 25.7% in the fourth quarter.
ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock worth $270,396,000 after buying an additional 1,236,671 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of Nutrien by 78.8% in the third quarter.
Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock worth $121,271,000 after buying an additional 1,100,000 shares during the period. Silchester International Investors LLP increased its holdings in shares of Nutrien by 9.5% in the fourth quarter.
Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock worth $523,268,000 after buying an additional 1,009,895 shares during the period. Finally, Toronto Dominion Bank increased its holdings in shares of Nutrien by 11.9% in the third quarter.
Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock worth $202,830,000 after buying an additional 447,413 shares during the period. Hedge funds and other institutional investors own 63.10% of the company’s stock.
Nutrien Stock PerformanceNutrien stock opened at $50.54 on Tuesday. The stock’s 50 day simple moving average is $50.
84 and its two-hundred day simple moving average is $48.61. The company has a debt-to-equity ratio of 0.
38, a quick ratio of 0.82 and a current ratio of 1.27.
The stock has a market cap of $24.73 billion, a price-to-earnings ratio of 36.89, a PEG ratio of 1.
19 and a beta of 0.81. Nutrien Ltd.
has a fifty-two week low of $43.70 and a fifty-two week high of $60.87.
Nutrien (NYSE:NTR – Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.
37 by ($0.09). Nutrien had a net margin of 2.
62% and a return on equity of 6.81%. The firm had revenue of $5.
08 billion for the quarter, compared to the consensus estimate of $5.09 billion. As a group, analysts expect that Nutrien Ltd.
will post 3.72 earnings per share for the current fiscal year. Nutrien Cuts DividendThe business also recently declared a quarterly dividend, which will be paid on Thursday, April 10th.
Investors of record on Monday, March 31st will be paid a $0.545 dividend. The ex-dividend date is Monday, March 31st.
This represents a $2.18 annualized dividend and a dividend yield of 4.31%.
Nutrien’s payout ratio is currently 159.12%. Analysts Set New Price TargetsSeveral research firms have recently commented on NTR.
Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $58.00 to $60.00 in a report on Tuesday, December 3rd.
CIBC lifted their price objective on Nutrien from $64.00 to $66.00 and gave the stock an “outperformer” rating in a report on Tuesday, February 25th.
Barclays raised their target price on Nutrien from $56.00 to $59.00 and gave the stock an “equal weight” rating in a research note on Wednesday, March 5th.
UBS Group raised their target price on Nutrien from $53.00 to $54.00 and gave the stock a “neutral” rating in a research note on Thursday, February 20th.
Finally, JPMorgan Chase & Co. raised Nutrien from an “underweight” rating to a “neutral” rating and raised their target price for the stock from $40.00 to $50.
00 in a research note on Monday, January 13th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.
com, Nutrien presently has a consensus rating of “Moderate Buy” and a consensus target price of $60.13.Read Our Latest Analysis on NutrienAbout Nutrien (Free Report)Nutrien Ltd.
provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products.
The Potash segment provides granular and standard potash products.Featured ArticlesFive stocks we like better than NutrienBusiness Services Stocks InvestingHow to Protect Your Portfolio When Inflation Is Rising3 Grocery Stocks That Can Help Take a Bite Out of Inflation 3 Tech Stocks Defying Sector Weakness and Thriving in 2025The Significance of a Trillion-Dollar Market Cap Goes Beyond a NumberDespite Challenges Novo Nordisk Plans to Crush GLP-1 CompetitorsWant to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd.
(NYSE:NTR – Free Report)..
